Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Pulnovo Medical Inc. currently has 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These 2 actions are handled by 2 distinct examiners, meaning each examiner is reviewing 1 application. Both matters are situated within 1 distinct art unit, centralizing the technical review process for the company's medical device filings.
The busiest examiner, KHANDKER, RAIHAN R, is assigned to 1 busiest examiner pending action. With 2 pending office actions split between 2 distinct examiners, there is no single dominant reviewer for the portfolio. However, the concentration in 1 distinct art unit is significant for practitioners. It suggests that the technical standards and legal interpretations applied to the 2 pending office actions will likely be consistent, as they are being managed within the same administrative unit. Practitioners should focus on the specific requirements of this 1 art unit while also addressing the individual feedback from the 2 different examiners. This balance of 2 distinct examiners within 1 distinct art unit allows for a targeted prosecution strategy that leverages the technical consistency of the 1 art unit while remaining sensitive to individual examiner preferences.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KHANDKER, RAIHAN R | 1 | 64.2% | +57.2% |
| DELLA, JAYMI E | 1 | 68.8% | +29.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18970393 | MULTI-CATHETER SYSTEMS FOR TREATING HEART FAILURE | KHANDKER, RAIHAN R | — |
| 18779373 | MULTI-POLE SYNCHRONOUS PULMONARY ARTERY RADIOFREQUENCY ABLATION CATHETER | DELLA, JAYMI E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18970393 | MULTI-CATHETER SYSTEMS FOR TREATING HEART FAILURE | KHANDKER, RAIHAN R | — |
| 18779373 | MULTI-POLE SYNCHRONOUS PULMONARY ARTERY RADIOFREQUENCY ABLATION CATHETER | DELLA, JAYMI E | — |
| Art Unit | Apps |
|---|---|
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18970393 | MULTI-CATHETER SYSTEMS FOR TREATING HEART FAILURE | KHANDKER, RAIHAN R | 3771 | §103§112 | Non-Final OA | — | Pending | Dec 05, 2024 |
| 18779373 | MULTI-POLE SYNCHRONOUS PULMONARY ARTERY RADIOFREQUENCY ABLATION CATHETER | DELLA, JAYMI E | — | §101§102§112DP | Non-Final OA | — | Pending | Jul 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial